Structure |
Chemical Name |
CAS |
MF |
|
2-Isopropylthieno[3,2-d]pyrimidin-4(3H)-one |
443149-44-8 |
C9H10N2OS |
|
13,14-DIHYDRO-15-KETO PROSTAGLANDIN D2 |
59894-07-4 |
C20H32O5 |
|
ETHYL 3-BUTENOATE |
1617-18-1 |
C6H10O2 |
|
Secondary Prostaglandin Metabolite LC-MS Mixture |
|
|
|
5,11-Dihydropyrido[2,3-b][1,4]benzodiazepin-6-one |
885-70-1 |
C12H9N3O |
|
3-CYANOCOUMARIN |
15119-34-3 |
C10H5NO2 |
|
Indoline |
496-15-1 |
C8H9N |
|
4-Methylimidazole |
822-36-6 |
C4H6N2 |
|
9-Fluorenol |
1689-64-1 |
C13H10O |
|
1H-Tetrazole-1-acetic acid |
21732-17-2 |
C3H4N4O2 |
|
Ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate |
64485-82-1 |
C7H9N3O3S |
|
(+)-beta-Pinene oxide |
6931-54-0 |
C10H16O |
|
TETRAMISOLE |
|
C11H12N2S |
|
ethyl 3-methyl-2,4-dioxo-1H-pyrimidine-5-carboxylate |
154942-22-0 |
C8H10N2O4 |
|
5-(Acetamido)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide |
31127-80-7 |
C16H20I3N3O7 |
|
Derivatives intermediate 3 |
1213710-50-9 |
C21H30N2O |
|
Lixivaptan intermediate-V |
168079-19-4 |
C19H16ClN3O |
|
TETRABENAZINE |
58-46-8 |
C19H27NO3 |
|
2',3'-Anhydroinosine |
31766-13-9 |
C10H10N4O4 |
|
(2S)-2-(2,6-Dichlorophenyl)-1-[(1R)-1-phenylethyl]-4-imidazolidinone |
1004754-99-7 |
C17H16Cl2N2O |
|
bk-DMBDB (hydrochloride) |
17763-12-1 |
C13H18ClNO3 |
|
Methyl 1,4,5,6-tetrahydro-4,6-dioxopyridine-3-carboxylate |
88499-68-7 |
C7H7NO4 |
|
2-CHLORO-5-FLUORO-4-METHOXY-6-METHYLPYRIMIDINE |
1192479-35-8 |
C6H6ClFN2O |
|
N-ForMyl- |
104872-27-7 |
C29H53NO5 |
|
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine |
1022150-12-4 |
C22H22N6O |
|
2-Chloro-5,6,7,8-tetrahydro-pyrido[3,4-d]pyriMidine |
1196153-06-6 |
C7H8ClN3 |
|
2-Ethylhexyl-4,6-dibroMo-3-fluorothieno[3,4-b]thiophene-2-carboxylate |
1237479-38-7 |
C15H17Br2FO2S2 |
|
4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline |
190728-25-7 |
C17H16N2O3 |
|
McMMAE |
863971-24-8 |
C49H78N6O10 |
|
2-Amino-4-bromo-3-fluorobenzoic acid |
1416013-62-1 |
C7H5BrFNO2 |
|
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
1246391-73-0 |
C37H42F2N8O4 |
|
2,4-Bis([1,1'-biphenyl]-4-yl)-6-chloro-1,3,5-triazine |
182918-13-4 |
C27H18ClN3 |
|
Neratinib Maleate |
915942-22-2 |
C34H33ClN6O7 |
|
Oclacitinib Maleate(PF-03394197) |
1208319-27-0 |
C19H27N5O6S |
|
Methyl 3,3-difluorocyclopentanecarboxylate |
1394129-94-2 |
C7H10F2O2 |
|
8-chloro-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one |
1260585-12-3 |
C8H7ClF3N3O |
|
Intermediate of Rolapitant |
205654-80-4 |
C23H19NO4 |
|
1,4-Thioxane-1,1-dioxide |
107-61-9 |
C4H8O3S |
|
4,6,7-trihydroxycoumarin |
22649-24-7 |
C9H6O5 |
|
Velpatasvir intermediate |
1378391-42-4 |
C31H34BrNO8 |
|
2-amino-5-nitro-4,6-pyrimidinedione |
301315-87-7 |
C4H4N4O4 |
|
tert-butyl (S)-2-cyanoazetidine-1-carboxylate |
556835-05-3 |
C9H14N2O2 |
|
(2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester |
1420478-88-1 |
C18H18BrN5O2 |
|
2-Bromo-4-methoxy-6-methylpyrimidine |
56545-10-9 |
C6H7BrN2O |
|
ethyl 6-bromobenzofuran-3-carboxylate |
1260799-56-1 |
C11H9BrO3 |
|
1-(biphenyl-4-yl)-2-methyl-2-morpholinopropan-1-one |
94576-68-8 |
C20H23NO2 |
|
(9H-fluoren-9-yl)methyl (4-(dimethoxymethyl)phenyl)carbamate |
475160-88-4 |
C24H23NO4 |
|
Posaconazole Impurity 18 |
213381-06-7 |
C37H42F2N8O4 |
|
4-Pyrimidinamine,5-(chloromethyl)-2-methyl-, hydrochloride (1:1) |
70476-08-3 |
C6H9Cl2N3 |
|
2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile |
1187594-13-3 |
C22H31N7O3SSi |
|
Δ3-Flomoxef sodium |
|
|
|
2,3,6,7,14,15-Hexabromo-9,10-dihydro-9,10-[1,2]benzenoanthracene |
55805-81-7 |
C20H8Br6 |
|
ETHYL 6-NITRO-1H-INDOLE-2-CARBOXYLATE |
16792-45-3 |
C11H10N2O4 |
|
2,5-DICHLORO-4,6-DIMETHYLNICOTINONITRILE |
91591-63-8 |
C8H6Cl2N2 |
|
1-CYCLOPROPYLMETHYL-PIPERAZINE DIHYDROCHLORIDE |
373608-42-5 |
C8H18Cl2N2 |
|
disodium 4,5-dihydro-5-oxo-4-(phenylazo)-1-(4-sulphonatophenyl)-1H-pyrazole-3-carboxylate |
1934-22-1 |
C16H10N4Na2O6S |
|
3-acetyl-4-hydroxy-2-benzopyrone |
2555-37-5 |
C11H8O4 |
|
Benzenamine, 4,4',4''-(2,4,6-pyrimidinetriyl)tris- (9CI) |
136009-19-3 |
C22H19N5 |
|
Cyclopenta[d]-1,2,3-oxathiazole-3(3aH)-carboxylic acid, tetrahydro-, 1,1-dimethylethyl ester, 2,2-dioxide, (3aS,6aR)- |
2145122-45-6 |
C10H17NO5S |
|
4-MAR |
|
|
|
Δ3-Ceftiofur |
|
|
|
tert-butyl (3R)-3-(2-((2S,5R)-6-(benzyloxy)-7-oxo- 1,6-diazabicyclo[3.2.1]octane-2-carbonyl)hydrazine-1-carbonyl)pyrrolidine-1-carboxylate |
1463527-14-1 |
C24H33N5O6 |
|
Ethanaminium, N -[7-(ethylamino)-8-methyl-3 H -phenoxazin-3-ylidene]-2-[2-(2-methoxyethoxy)ethoxy]- N -[2-[2-(2-methoxyethoxy)
ethoxy]ethyl]- (ACI) |
2664217-62-1 |
C29H44N3O7+ |
|
N-(4-CYANO-PHENYL)-GLYCINE |
42288-26-6 |
C9H8N2O2 |
|
DeoxyBenzoinOxime |
952-06-7 |
C14H13NO |
|
(2S,5R)-6-(tert-butyldimethylsilyloxy)-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-ene-2-carboxamide |
2209874-02-0 |
C14H25N3O3Si |
|
20-hydroxy Prostaglandin F2a |
|
|
|
1,6-Diazabicyclo[3.2.1]oct-3-ene-2-carboxamide, 6-hydroxy-3-methyl-7-oxo-, (1R,2S,5R)- |
2209874-17-7 |
C8H11N3O3 |
|
3-Acetylbiphenyl |
3112-01-4 |
C14H12O |
|
7H-Pyrrolo[2,3-d]pyrimidine, 2-methyl- (7CI) |
89792-07-4 |
C7H7N3 |
|
Pneumocandin B0 |
135575-42-7 |
C50H80N8O17 |
|
S)-3-Cyano-5-methyl hexanoic acid ethyl ester |
181289-39-4 |
C10H17NO2 |
|
Trityl candesartan cilexetil |
170791-09-0 |
C52H48N6O6 |
|
5.7-Dioxa-6-thia-spiro[2.5]octane-6-oxide |
89729-09-9 |
C5H8O3S |
|
2-Propenoic acid, 3-[1-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-β-D-erythro-pentofuranosyl]-1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl]-, (2E)- |
923023-62-5 |
C33H32N2O9 |
|
8-Benzyloxy-2'-deoxy-D-guanosine |
96964-90-8 |
C17H19N5O5 |
|
ethyl brevifolincarboxylate |
107646-82-2 |
C15H12O8 |
|
3-FLUOROINDOLE |
66946-81-4 |
C8H6FN |
|
Cefetecol |
117211-03-7 |
C20H17N5O9S2 |
|
4-METHYL-2-PYRROLECARBOXYLIC ACID ETHYL ESTER |
40611-85-6 |
C8H11NO2 |
|
2-Amino-5-nitrothiazole |
121-66-4 |
C3H3N3O2S |
|
Benzo[d]Isothiazole |
272-16-2 |
C7H5NS |
|
(R)-ethyl thiazolidine-4-carboxylate |
|
C6H11NO2S |
|
Ranolazine-d3 |
1054624-77-9 |
C24H33N3O4 |
|
1-BENZYL-PYRROLIDINE-3-CARBONITRILE |
10603-52-8 |
C12H14N2 |
|
(+)-(4S)-PHENYL-ALPHA-[(4S)-PHENYLOXAZOLIDIN-2-YLIDENE]-2-OXAZOLINE-2-ACETONITRILE |
150639-33-1 |
C20H17N3O2 |
|
5-BENZYLIDENEHYDANTOIN |
3775-01-7 |
C10H8N2O2 |
|
4-Chloro-N-methylpiperidine |
5570-77-4 |
C6H12ClN |
|
5-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-hexanoic acid ethyl ester |
147125-14-2 |
C33H56O3Si |
|
Clopidogrel camphorsulfonate |
120202-68-8 |
C26H32ClNO6S2 |
|
4,6-Dimethyl-2-methylsulfonylpyrimidine |
35144-22-0 |
C7H10N2O2S |
|
(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity) |
130793-28-1 |
C29H55NO6 |
|
Androsta-3,5-diene-7,17-dione |
1420-49-1 |
C19H24O2 |
|
N4-Acetyl-2'-O-Methyl-cytidine |
113886-71-8 |
C12H17N3O6 |
|
5-Methyl-1H-hexahydropyrrolo[3,4-b]pyrrole |
132414-59-6 |
C7H14N2 |
|
2-Hydroxy-6-methyl-pyrimidine-4-carboxylic acidhydrochloride |
1185300-30-4 |
C6H7ClN2O3 |
|
(R)-4-[(1-METHYLHEPTYLOXY)CARBONYL]PHENYL 4'-OCTYLOXY-4-BIPHENYLCARBOXYLATE |
123286-51-1 |
C36H46O5 |
|
4,4'-Dibromo-2,2'-diiodobiphenyl |
852138-89-7 |
C12H6Br2I2 |
|
Sterolazole intermediate |
|
|
|
ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate |
6825-71-4 |
C6H10N4O2 |